Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANIBIZUMAB vs RANOLAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RANIBIZUMAB vs RANOLAZINE: Safety Overview

Metric RANIBIZUMAB RANOLAZINE
Total FAERS Reports 15,284 9,522
Deaths Reported 2,651 1,048
Death Rate 17.3% 11.0%
Hospitalizations 2,265 3,367
Average Patient Age 71.7 yrs 70.4 yrs
% Female Patients 52.5% 42.0%
FDA Approval Date N/A Apr 15, 2025
Manufacturer Coherus BioSciences Inc AvKARE
Route INTRAVITREAL ORAL
Marketing Status Prescription Discontinued